Valuation: Medpace Holdings, Inc.

Market Cap 16.14B 14.12B 13.02B 12.06B 22.9B 1,532B 23.27B 156B 60.69B 756B 60.59B 59.28B 2,613B P/E 2026 *
33.3x
P/E 2027 * 30.5x
Enterprise Value 14.97B 13.1B 12.07B 11.19B 21.24B 1,421B 21.58B 145B 56.3B 701B 56.2B 54.98B 2,424B EV / Sales 2026 *
5.4x
EV / Sales 2027 * 4.93x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day-3.33%
1 week+3.15%
Current month+3.15%
1 month+19.30%
3 months+7.43%
6 months-10.90%
Current year-2.73%
1 week 530.98
Extreme 530.975
567.91
1 month 445
Extreme 445.005
567.91
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
06-29Fiscal year

Director

72 0.0003%
06-29Fiscal year

Director

56 0.0002%
06-29Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-3.33%+3.15%+71.30%+131.94% 16.14B
-1.03%+5.24%+2.94%+9.41% 50.25B
+0.25%+1.70%+419.39%+621.71% 40.39B
+1.10%+7.77%+28.18%-3.96% 34.38B
-0.16%+8.42%+28.20%+63.00% 34.4B
+1.31%-0.56%+5.12%+33.90% 26.32B
-0.35%+0.09% - - 16.64B
+0.32%+0.53%+14.33%+21.47% 13.71B
+3.79%+8.88%+106.63%+106.63% 13.75B
-1.63%+9.78%+1,764.71%+697.48% 12.69B
Average +0.07%+8.75%+271.20%+186.84% 25.87B
Weighted average by Cap. +0.08%+6.58%+183.30%+170.42%

Financials

2026 *2027 *
Net sales 2.77B 2.43B 2.24B 2.07B 3.94B 263B 4B 26.83B 10.43B 130B 10.42B 10.19B 449B 2.95B 2.58B 2.38B 2.2B 4.18B 280B 4.25B 28.5B 11.08B 138B 11.06B 10.82B 477B
Net income 493M 431M 397M 368M 699M 46.76B 710M 4.76B 1.85B 23.08B 1.85B 1.81B 79.76B 540M 473M 436M 404M 766M 51.25B 779M 5.22B 2.03B 25.29B 2.03B 1.98B 87.43B
Net Debt -1.17B -1.02B -943M -874M -1.66B -111B -1.69B -11.3B -4.4B -54.75B -4.39B -4.29B -189B -1.62B -1.42B -1.3B -1.21B -2.3B -154B -2.33B -15.65B -6.08B -75.78B -6.07B -5.94B -262B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-07 US$546.29 -3.33% 356,311
26-07-06 US$565.09 +1.34% 234,162
26-07-02 US$557.60 +2.58% 356,575
26-07-01 US$543.57 +2.64% 312,635
26-06-30 US$529.59 -0.96% 335,554
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
565.09USD
Average target price
445.58USD
Spread / Average Target
-21.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock